Evolution of the Average Target: IMPACT Therapeutics, Inc

Evolution of the Target Price: IMPACT Therapeutics, Inc

Changes in Analyst Recommendations: IMPACT Therapeutics, Inc

c464d99add4a187257d8f.1ONY93Kvkb4nJilMjTVdXnCOm9fLhjTpCQzcDbqYO78.5oUczwbcpMdWEHoU9GJwaQXt8r2N4lu8QUm-Z_mpQ_m9zhTEQOXC60FvcA~431f857631292c7102d503e594344219

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - - +126.33%
+11.79%
+21.92%
+19.64%
+7.4%
+25.43%
+18.27%
+50.7%
+3.91%
+73.24%
Average +35.86%
Weighted average by Cap. +22.33%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
12.03CNY
Average target price
27.28CNY
Spread / Average Target
+126.79%
High Price Target
27.28CNY
Spread / Highest target
+126.79%
Low Price Target
27.28CNY
Spread / Lowest Target
+126.79%

Analyst Consensus Detail

Consensus revision (last 18 months)

  1. Stock Market
  2. Stocks
  3. 7630 Stock
  4. Consensus IMPACT Therapeutics, Inc